Cambridge Nutritional Sciences plc
CNSL.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.27 | 0.03 | -0.00 |
| FCF Yield | -1.95% | 6.78% | -46.10% | -66.94% |
| EV / EBITDA | 1.25 | -72.43 | -0.80 | -15.17 |
| Quality | ||||
| ROIC | -5.37% | -1.89% | -21.55% | -5.76% |
| Gross Margin | 60.08% | 61.86% | 42.05% | 55.62% |
| Cash Conversion Ratio | 0.05 | -1.85 | 0.82 | 0.28 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.35% | 4.61% | 3.45% | -4.55% |
| Free Cash Flow Growth | -125.91% | 116.58% | 29.79% | 10.24% |
| Safety | ||||
| Net Debt / EBITDA | -2.06 | 38.29 | 1.90 | 3.23 |
| Interest Coverage | -37.65 | -24.32 | -213.77 | -27.71 |
| Efficiency | ||||
| Inventory Turnover | 4.01 | 6.14 | 5.63 | 3.46 |
| Cash Conversion Cycle | 84.34 | 63.15 | 106.31 | 183.78 |